A detailed history of Prevail Innovative Wealth Advisors, LLC transactions in Bioventus Inc. stock. As of the latest transaction made, Prevail Innovative Wealth Advisors, LLC holds 128,157 shares of BVS stock, worth $1.44 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
128,157
Holding current value
$1.44 Million
% of portfolio
0.47%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.73 - $11.95 $734,339 - $1.53 Million
128,157 New
128,157 $1.53 Billion

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $693M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Prevail Innovative Wealth Advisors, LLC Portfolio

Follow Prevail Innovative Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prevail Innovative Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prevail Innovative Wealth Advisors, LLC with notifications on news.